BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 21980925)

  • 1. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
    Kolli CS; Xiao J; Parsons DL; Babu RJ
    Drug Dev Ind Pharm; 2012 May; 38(5):571-6. PubMed ID: 21980925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles.
    Singh ND; Banga AK
    J Drug Target; 2013 May; 21(4):354-66. PubMed ID: 23311703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulated iontophoretic delivery of small and large molecules through microchannels.
    Kumar V; Banga AK
    Int J Pharm; 2012 Sep; 434(1-2):106-14. PubMed ID: 22633929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
    Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
    Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
    Dubey S; Kalia YN
    J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro.
    Kolli CS; Chadha G; Xiao J; Parsons DL; Babu RJ
    J Drug Target; 2010 Nov; 18(9):657-64. PubMed ID: 20038213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro transdermal iontophoretic delivery of penbutolol sulfate.
    Ita KB; Banga AK
    Drug Deliv; 2009 Jan; 16(1):11-4. PubMed ID: 19555303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal iontophoresis of the dopamine agonist 5-OH-DPAT in human skin in vitro.
    Nugroho AK; Li L; Dijkstra D; Wikström H; Danhof M; Bouwstra JA
    J Control Release; 2005 Mar; 103(2):393-403. PubMed ID: 15763622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microneedle Mediated Iontophoretic Delivery of Tofacitinib Citrate.
    Dandekar AA; Garimella HT; German CL; Banga AK
    Pharm Res; 2023 Mar; 40(3):735-747. PubMed ID: 35174431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulated delivery of donepezil using a combination of skin microporation and iontophoresis.
    Kale M; Kipping T; Banga AK
    Int J Pharm; 2020 Nov; 589():119853. PubMed ID: 32898633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro.
    Kumar MG; Lin S
    Pharm Dev Technol; 2009; 14(1):106-15. PubMed ID: 18825546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles.
    Li G; Badkar A; Nema S; Kolli CS; Banga AK
    Int J Pharm; 2009 Feb; 368(1-2):109-15. PubMed ID: 18996461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microneedle-assisted delivery of verapamil hydrochloride and amlodipine besylate.
    Kaur M; Ita KB; Popova IE; Parikh SJ; Bair DA
    Eur J Pharm Biopharm; 2014 Feb; 86(2):284-91. PubMed ID: 24176676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
    Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
    Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist.
    Yamamoto R; Takasuga S; Yoshida Y; Mafune S; Kominami K; Sutoh C; Kato Y; Yamauchi M; Ito M; Kanamura K; Kinoshita M
    Int J Pharm; 2012 Jan; 422(1-2):132-8. PubMed ID: 22108639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
    Nair A; Vyas H; Shah J; Kumar A
    Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro and in-vivo transdermal iontophoretic delivery of tramadol, a centrally acting analgesic.
    Takasuga S; Yamamoto R; Mafune S; Sutoh C; Kominami K; Yoshida Y; Ito M; Kinoshita M
    J Pharm Pharmacol; 2011 Nov; 63(11):1437-45. PubMed ID: 21988424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lipophilicity on microneedle-mediated iontophoretic transdermal delivery across human skin in vitro.
    Pawar KR; Smith F; Kolli CS; Babu RJ
    J Pharm Sci; 2013 Oct; 102(10):3784-91. PubMed ID: 23955316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin.
    Chen H; Zhu H; Zheng J; Mou D; Wan J; Zhang J; Shi T; Zhao Y; Xu H; Yang X
    J Control Release; 2009 Oct; 139(1):63-72. PubMed ID: 19481577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.